Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop
À¶Ý®ÊÓƵ
Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop ONCOIMMUNOLOGY Houot, R., Gaulard, P., Schreiber, R., Mellman, I., Lambotte, O., Coulie, P. G., Fest, T., Korman, A., Levy, R., Shipp, M., Tarte, K., Kohrt, H., Marabelle, A., Ansell, S., Watier, H., van Elsas, A., Balakumaran, A., Vargas, F. A., Quezada, S. A., Salles, G., Olive, D. 2016; 5 (7)Abstract
In November 2015, the CALYM Carnot Institute held a 2-d workshop to discuss the current and future development of immunomodulatory antibodies for the treatment of lymphoma. Highlights from the workshop are presented in this article.
View details for
View details for
View details for
View details for